INTEREST RATES   Federal Reserve Chair Janet Yellen said Wednesday that the U.S. central bank remains on track to both raise interest rates

YELLEN MAINTAINS PLAN TO HIKE INTEREST RATES, SHRINK BALANCE SHEET

YELLEN MAINTAINS PLAN TO HIKE INTEREST RATES, SHRINK BALANCE SHEET

 INTEREST RATES   Federal Reserve Chair Janet Yellen said Wednesday that the U.S. central bank remains on track to both raise interest rates

FOREX INVESTORS BUZZ INTEREST RATES   Federal Reserve Chair Janet Yellen said Wednesday that the U.S. central bank remains on track to both raise interest rates and begin shrinking its balance sheet before the end of the year.

In prepared remarks released before her testimony to the House Financial Services committee, Yellen said the Fed is likely to unwind its stimulus despite low inflation.

“The Committee continues to expect that the evolution of the economy will warrant gradual increases in the federal funds rate over time to achieve and maintain maximum employment and stable prices.”



INTEREST RATES

 

Her testimony to the Senate Banking Committee will start at 10:00AM ET (1400GMT).

The Fed hiked rates at its June meeting and stuck to its forecast for one more rate hike this year, but the subdued inflation outlook has since raised doubts over whether the U.S. central bank will be able to stick to its planned tightening path.

Futures traders are pricing in around a 40% chance of a hike by the end of the year, according to Investing.com’s Fed Rate Monitor Tool.

USD/JPY was at 113.30 from 113.54 earlier, EUR/USD was trading at 1.1473 from around 1.1447 ahead of the release of the comments, while GBP/USD was at 1.2895 from 1.2877 earlier.

The US dollar index, which tracks the greenback against a basket of six major rivals, was at 95.35, compared to 95.54 shortly before Yellen’s remarks.

Meanwhile, U.S. stock futures pointed to a higher open. The Dow futures rose 64 points, or 0.3%, the S&P 500 futures added 7 points, or 0.3%, while the Nasdaq 100 futures tacked on 26 points, or 0.5%.

Elsewhere, in the commodities market, gold futures traded at $1,218.39 a troy ounce, compared to $1,214.67 ahead of the data, while crude oil traded at $45.73 a barrel from $45.69 earlier.

Like up on FACEBOOK


logo



major currencies: (EUR-USD) (USD-JPY) (USD-GBP) (USD-CHF), (USD-CAD), (AUD-USD) (USDCNY)



Cryptobuyer Emerges as a Leader  Cryptobuyer, a leading cryptocurrency and digital assets company in the Latin America has gained the distinction of being the first company ever to install Bitcoin ATMs (BTMs) in a commercial bank after two of its BTMs found a place in the premises of Banistmo Bank’s headquarters. The instal

Cryptobuyer Emerges as a Leader in Latin America with an Aggressive Expansion Plan

Cryptobuyer installed the first Bitcoin ATMs in a commercial bank as it announced plans for expansion, ICO, and the new Blockchain Academy Latam.

Cryptobuyer Emerges as a Leader  Cryptobuyer, a leading cryptocurrency and digital assets company in the Latin America has gained the distinction of being the first company ever to install Bitcoin ATMs <span data-recalc-dims=(BTMs) in a commercial bank after two of its BTMs found a place in the premises of Banistmo Bank’s headquarters. The instal" width="300" height="171" srcset="https://i0.wp.com/investorsbuz.com/wp-content/uploads/2017/06/Bitcoin-PR-Buzz-Cryptobuyer-Latin-America-.png?resize=300%2C171 300w, https://i0.wp.com/investorsbuz.com/wp-content/uploads/2017/06/Bitcoin-PR-Buzz-Cryptobuyer-Latin-America-.png?resize=768%2C438 768w, https://i0.wp.com/investorsbuz.com/wp-content/uploads/2017/06/Bitcoin-PR-Buzz-Cryptobuyer-Latin-America-.png?w=975 975w" sizes="(max-width: 300px) 100vw, 300px" />

BUZ INVESTORS  PRESS RELEASE  Cryptobuyer Emerges as a Leader  Cryptobuyer, a leading cryptocurrency and digital assets company in the Latin America has gained the distinction of being the first company ever to install Bitcoin ATMs (BTMs) in a commercial bank after two of its BTMs found a place in the premises of Banistmo Bank’s headquarters. The installation of BTMs followed the recently concluded Panamanian Association of Fintech event. Cryptobuyer was one of the participants at the second edition of the event which was hosted by the second largest bank in Panama, Banistmo. The event witnessed widespread participation from the members of banking and finance community and the general public.

The CEO, Jorge Luis Farias was part of a panel of experts discussing the scope and applications of blockchain technology at the event. The panel discussion garnered the attention of over 300 participants from various industry sectors. The participation of Cryptobuyer in the Panamanian Association of Fintech event coincided with a recent report on Bloomberg covering the company and its use of blockchain technology to solve real world problems in the lives of people in emerging countries like Venezuela – a nation that is currently affected by hyperinflation and capital controls.




 Cryptobuyer Emerges as a Leader

Farias, along with the CEO of Tigo CTM Cindy Zimmerman and the founder of Guldcoin Ira Miller, both technology partners of Cryptobuyer showcased the two BTMs installed within the bank. These state-of-the-art machines supporting both Bitcoin and DASH were well received as many people in attendance lined up to test the equipment. The company plans to install more than 20 of these Bitcoin ATMs across Panama and rest of South America as the first phase of its effort to create a cryptocurrency ATM network in the region.

The Global Business Developer at DASH, Daniel Diaz also took part in the panel and spoke about the advantages of DASH as one of the most promising cryptocurrencies. Cryptobuyer, recognizing the cryptocurrency’s potential announced support for DASH during the same event. Other prominent members in attendance at the event included Yari Romero, the CIO of CBChains.com – a venture capital, startup, and blockchain consulting firm, Alejandro de la Torre from BTC.com, Felipe Echandi Founder of Quanto mobile digital payments application and PanaFintech, Alejandro Palomar of Blockchain 360 Solutions and KPMG’s Glenn Tjon.

BTC.com’s Alejandro de la Torre, who came all the way from Amsterdam demonstrated the use of Bitcoin wallet and gave away over 100 gift codes, to be redeemed on BTC.com wallet for Bitcoin. Similarly, Palomar enlightened the audience about Blockchain technology while Tjon touched upon the impact of distributed ledger technology on global organizations.

After the panel discussion, Cryptobuyer announced its entry into the Ciudad del Saber (City of Knowledge) technology and innovation campus to set up base alongside 180 world-class companies and organizations including the likes of the United Nations, Copa Airlines, IESA and Hewlett-Packard. Cryptobuyer while setting up its headquarters in the technology hub will also develop Blockchain Academy Latam to impart cryptocurrency related education, training, and certifications to individuals, companies and organizations from Latin America and rest of the world.

And finally, the big news. The company also announced its plans for an ICO in the coming weeks as the company looks forward to expanding its business model and operations with a soon-to-be-launched product. More details about the ICO and the new product launch will be announced soon.

About Cryptobuyer

Cryptobuyer is a leading digital assets company working on providing simple, fast and robust solutions involving cryptocurrencies. The company offers solutions that connect virtual currencies to day-to-day, real-world interactions. The company also provides cryptocurrency and blockchain consultancy services to individuals, groups, businesses and organizations. Cryptobuyer is a partner of the Bitcoin Foundation of Venezuela and the Panamanian Fintech Association.

Learn more about Cryptobuyer at – https://cryptobuyer.io

|Chart | Calendar   | TRADE NOW | FORCAST | cryptocurrency 

Market Quotes by TradingView

Like up on FACEBOOK


logo




BUZ INVESTORS GOP Healthcare Bill Repealing and replacing Obamacare and reforming the tax code are two of President Donald Trump's top priorities,

Voters Disapprove Of GOP Healthcare Bill, Trump Tax Plan

Chart | Calendar   | TRADE NOW | healthcare

Voters Disapprove Of GOP Healthcare Bill, Trump Tax Plan

BUZ INVESTORS GOP Healthcare Bill Repealing and replacing Obamacare and reforming the tax code are two of President Donald Trump's top priorities,

BUZ INVESTORS  GOP Healthcare Bill Repealing and replacing Obamacare and reforming the tax code are two of President Donald Trump’s top priorities, but the results of a Quinnipiac University national poll show weak support for the proposals backed by the president.

Just 21 percent of voters approve of the Republican healthcare plan passed by the House last week, while 56 percent disapprove of the bill.

A plurality of Republicans support the GOP bill, but Quinnipiac said every other listed party, gender, educational, age and racial group opposes the plan.

The House voted 217 to 213 in favor of the healthcare bill last Thursday, although Senate Republicans have indicated they plan to craft their own legislation.

Democrats are likely to maintain their fierce opposition to any GOP proposal to repeal Obamacare amid expectations the strategy will benefit them in next year’s midterm elections.

The poll also found that 52 percent of voters disapprove of the tax reform plan the Trump administration unveiled last month, although 30 percent approve.

Quinnipiac said disapproval of the tax plan rises to 74 percent, including 66 percent of Republicans, if the plan “significantly increased the national deficit.”

Trump’s tax reform plan would reduce the number of income tax brackets from seven to three and lower the corporate tax rate to 15 percent from the current 35 percent.



 GOP Healthcare Bill

>>>TRADE NOW<<<

A majority of voters also said it is a “bad idea” to eliminate all tax deductions except for mortgage interest and charitable giving.Voters said 49 percent to 38 percent it is a “bad idea” to reduce the number of tax brackets and said 55 percent to 39 percent it is a “bad idea” to lower the corporate tax rate.

However, voters said 54 percent to 35 percent it is a “good idea” to increase the standard deduction and said 48 percent to 43 percent it is a “good idea” to eliminate the estate tax.

Sixty-three percent of voters predicted wealthy Americans would benefit most from the tax plan, while 27 percent said the middle class will benefit most.

Healthcare – Top 5 Gainers / Losers

Gainers: (DRRX) +15%. (PDEX) +10%. (SGMO) +10%. (RNN) +9%. (GERN) +8%.

Losers: (CAPR) -60%. (ARDX) -35%. (AKTX) -23%. (APRI) -13%. (APHB) -13%.

The Quinnipiac survey of 1,078 voters was conducted May 4th through 9th and has a margin of error of plus or minus 3 percentage points.

Repealing and replacing Obamacare and reforming the tax code are two of President Donald Trump’s top priorities, but the results of a Quinnipiac University national poll show weak support for the proposals backed by the president.

Just 21 percent of voters approve of the Republican healthcare plan passed by the House last week, while 56 percent disapprove of the bill.

A plurality of Republicans support the GOP bill, but Quinnipiac said every other listed party, gender, educational, age and racial group opposes the plan.

The House voted 217 to 213 in favor of the healthcare bill last Thursday, although Senate Republicans have indicated they plan to craft their own legislation.

Democrats are likely to maintain their fierce opposition to any GOP proposal to repeal Obamacare amid expectations the strategy will benefit them in next year’s midterm elections.

The poll also found that 52 percent of voters disapprove of the tax reform plan the Trump administration unveiled last month, although 30 percent approve.

Quinnipiac said disapproval of the tax plan rises to 74 percent, including 66 percent of Republicans, if the plan “significantly increased the national deficit.”

Trump’s tax reform plan would reduce the number of income tax brackets from seven to three and lower the corporate tax rate to 15 percent from the current 35 percent.
A majority of voters also said it is a “bad idea” to eliminate all tax deductions except for mortgage interest and charitable giving.Voters said 49 percent to 38 percent it is a “bad idea” to reduce the number of tax brackets and said 55 percent to 39 percent it is a “bad idea” to lower the corporate tax rate.

However, voters said 54 percent to 35 percent it is a “good idea” to increase the standard deduction and said 48 percent to 43 percent it is a “good idea” to eliminate the estate tax.

Sixty-three percent of voters predicted wealthy Americans would benefit most from the tax plan, while 27 percent said the middle class will benefit most.

The Quinnipiac survey of 1,078 voters was conducted May 4th through 9th and has a margin of error of plus or minus 3 percentage points.

Like up on FACEBOOK


logo



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )




BUZ INVESTORS IMMU Soars Today's Daily Dose brings you news about the much awaited regulatory event of TherapeuticsMD; strategic plan devised by Immunomedics; the next business milestone of Agile and news about Teva's CONCERTO trial.

TXMD All Set For D-day, IMMU Soars On Strategic Plan, CTSO On Watch

Chart | Calendar   | TRADE NOW | therapeutics

TXMD All Set For D-day, IMMU Soars On Strategic Plan, CTSO On Watch

BUZ INVESTORS  IMMU Soars  Today's Daily Dose brings you news about the much awaited regulatory event of TherapeuticsMD; strategic plan devised by Immunomedics; the next business milestone of Agile and news about Teva's CONCERTO trial.

BUZ INVESTORS  IMMU Soars  Today’s Daily Dose brings you news about the much awaited regulatory event of TherapeuticsMD; strategic plan devised by Immunomedics; the next business milestone of Agile and news about Teva’s CONCERTO trial.

Agile Therapeutics Inc. (AGRX) on Saturday reported additional results from SECURE, its phase III trial of investigational low-dose combined hormonal contraceptive patch Twirla.

The efficacy and safety results from the SECURE clinical trial were previously reported in January 2017. The newly reported bleeding profile shows a reduction in unscheduled bleeding/spotting days, noted the Company.

The SECURE study was conducted to address issues raised by the FDA in its 2013 Complete Response Letter to the company.

The Company will be re-submitting its NDA for Twirla by the end of the second quarter of 2017.

AGRX closed Friday’s trading at $3.37, down 2.88%.

CytoSorbents Corp. (CTSO) on Friday announced that the results of REFRESH 1 trial, which demonstrated safety and feasibility of CytoSorb, a blood purification technology, were presented on May 1, 2017 at the American Association for Thoracic Surgery Centennial Conference in Boston.

According to the trial results, CytoSorb treatment resulted in significant reduction of toxic inflammatory mediators during complex open heart surgery.

The Company plans to initiate a pivotal REFRESH 2 trial intended to support U.S. FDA approval of CytoSorb this year.

CytoSorb has been used safely in more than 20,000 human treatments to date. A companion product, VetResQ, based on similar underlying technology to CytoSorb, is now commercially available in the United States for the treatment of hyper-inflammatory conditions in animal health, noted the Company.

CTSO closed Friday’s trading at $4.85, up 1.04%.

Shares of Immunomedics Inc. (IMMU) were up over 17% on Friday on announcement of a new strategic plan to drive long-term value for stockholders.

The strategic plan includes the termination of the previously announced Exclusive Global Licensing Agreement with Seattle Genetics (SGEN), returning full rights of Sacituzumab Govitecan to Immunomedics.

Sacituzumab Govitecan is under phase II study in heavily pretreated patients with metastatic triple-negative breast cancer.

IMMU Soars

>>>TRADE NOW<<<

IMMU closed Friday’s trading at $6.36, up 17.56%.Immunomedics also announced that it has raised $125 million in gross proceeds in a private placement of its Series A-1 Convertible Preferred Stock with institutional investors, and has taken a series of steps to drive positive organizational and operational changes.

Teva Pharmaceutical Industries Ltd. (TEVA) and Active Biotech’s phase III trial of oral Laquinimod for the treatment of relapsing remitting multiple sclerosis, dubbed CONCERTO, has failed to meet the primary endpoint.

The trial’s primary endpoint was the time to Confirmed Disability Progression after at least 3 months, which was not met.

The Companies have decided not to pursue Laquinimod in relapsing remitting multiple sclerosis.

Teva continues to evaluate the potential of Laquinimod in primary progressive MS (PPMS) and Huntington disease (HD) with two other clinical trials unaffected by the results of the CONCERTO trial.

TEVA closed Friday’s trading at $31.14, up 0.87%.

Investors of TherapeuticsMD Inc. (TXMD) are eagerly waiting to know what the future holds for the Company’s drug candidate TX-004HR.

TX-004HR, also known as Yuvvexy, is an applicator-free vaginal estradiol softgel for the treatment of moderate-to-severe vaginal pain during sexual intercourse (dyspareunia), a symptom of vulvar vaginal atrophy (VVA) in postmenopausal women.
The FDA was supposed to have announced the decision of whether or not to approve Yuvvexy on May 7, 2017.

On April 10, 2017, the Company was informed that the FDA had identified deficiencies in the NDA for Yuvvexy. The deficiencies identified were not specified.

The company is scheduled to host a conference call and live audio webcast to provide a TX-004HR regulatory update on May 8, 2017.

TXMD closed Friday’s trading at $4.67, up 3.55%.

Like up on FACEBOOK


Ebates Coupons and Cash Back



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )

USDCAD Trump Shock Pushes Canadian Dollar Down

USDCAD Canadian Dollar Falls as Trump Tax Plan is Announced

USDCAD Canadian Dollar Falls as Trump Tax Plan is Announced

BUZ INVESTORS Canadian Dollar Falls The pair is trading at 1.3574 at 09:40 GMT this morning, with the USD trading 0.32% lower against CAD from the New York close

USDCAD

BUZ INVESTORS  Canadian Dollar Falls The pair is trading at 1.3574 at 09:40 GMT this morning, with the USD trading 0.32% lower against CAD from the New York close. The pair traded at a high of 1.3647 and a low of 1.3528 this morning. The US Dollar advanced against the Canadian Dollar in the New York session yesterday, closing 0.36% higher at 1.3617. On the data front, Canada’s retail sales surprisingly dropped on a monthly basis in February. The pair is expected to its find support at 1.3519 and its first resistance at 1.3638.



Canadian Dollar Falls

Canadian Dollar | Data | Chart | Calendar | Forecast | News

TRADE NOW

The USDCAD increased 0.0023 or 0.17% to 1.3636 on Thursday April 27 from 1.3613 in the previous trading session. Historically, the Canadian Dollar reached an all time high of 1.61 in January of 2002 and a record low of 0.92 in November of 2007.

The USDCAD spot exchange rate specifies how much one currency, the USD, is currently worth in terms of the other, the CAD. While the USDCAD spot exchange rate is quoted and exchanged in the same day, the USDCAD forward rate is quoted today but for delivery and payment on a specific future date. This page provides – Canadian Dollar – actual values, historical data, forecast, chart, statistics, economic calendar and news. Canadian Dollar – actual data, historical chart and calendar of releases – was last updated on April of 2017.

 

Like up on FACEBOOK


Ebates Coupons and Cash Back



major currencies: (EUR-USD) (USD-JPY) (USD-GBP) (USD-CHF), (USD-CAD), (AUD-USD)

Currency 1.36 Apr/17
Stock Market 15650 points Apr/17
Government Bond 10Y 1.58 % Apr/17

 

 




 

OTHER RELATED STORIES 

Canada S&P/TSX Toronto Stock Market Index | Data | Chart

Canada Inflation Rate MoM | 1950-2017 | Data | Chart | Calendar | Forecast

Best Canadian Marijuana Stocks Ahead of Canada Pot Legalization in 2018

Buz Investors Oil pushes higher on worries The commodity is trading at $53.74 per barrel at 10:40 GMT this morning, 0.19% higher from the New York close. Crude oil witnessed a high of $54.05

Crude Oil Price Recovery Aborted as Trump Tax Plan Disappoints

Crude Oil Price Recovery Aborted as Trump Tax Plan Disappoints

BUZ INVESTORS Oil Price Recovery Aborted The commodity is trading at $49.15 per barrel at 09:40 GMT this morning, 0.3% lower from the New York close

Oil

BUZ INVESTORS  Oil Price Recovery Aborted The commodity is trading at $49.15 per barrel at 09:40 GMT this morning, 0.3% lower from the New York close. Crude oil witnessed a high of $49.43 per barrel and a low of $48.95 per barrel during the session. In the New York session yesterday, crude oil rose 0.41% to close at $49.30 per barrel, after the EIA reported that US crude oil stockpiles declined more-than-anticipated by 3.64 million barrels to 528.70 million barrels last week. Immediate downside, the first support level is seen at $48.66 per barrel, while on the upside, the first resistance level is at $49.92 per barrel.

Oil Price Recovery Aborted

TRADE NOW

Crude oil | Data | Chart | Calendar | Forecast | News

Crude Oil decreased 0.98 USD/BBL or 1.98% to 48.74 on Thursday April 27 from 49.62 in the previous trading session. Historically, Crude oil reached an all time high of 145.31 in July of 2008 and a record low of 1.17 in February of 1946.

Crude oil is the world’s most actively traded commodity. Crude Oil prices displayed in Trading Economics are based on over-the-counter (OTC) and contract for difference (CFD) financial instruments. Our market prices are intended to provide you with a reference only, rather than as a basis for making trading decisions. Trading Economics does not verify any data and disclaims any obligation to do so. This page provides – Crude oil – actual values, historical data, forecast, chart, statistics, economic calendar and news. Crude oil – actual data, historical chart and calendar of releases – was last updated on April of 2017.

3 Offshore Drillers To Consider For A Potential Jack-Up Rebound Taking Shape Recently

  • The recent contract up-trend in the Jack-up segment is showing clearly, a nascent recovery starting end of 1Q 2017.
  • Looking at the fleet status of Rowan (RDC), Noble (NE) and Ensco (ESV) we see some very encouraging signs.
  • All three companies have a strong jack-up base that will support them financially until a full rebound occurs.

The offshore drilling industry plays an important role in the oil and gas supply chain; no one can deny this basic principle. Did you know that oil production from offshore locations represents about 29% of the global crude oil production in 2015, according to the EIA? This percentage has been nearly constant since 2005.

Like up on FACEBOOK
Market quotes are powered by
TradingView.com


Commodities ( Gold ) ( Silver ) ( Lithium )

Crude Oil 48.6422 0.98 -1.98 % -3.35% 0.44% 5.55% 09:48
Brent 50.8890 1.02 -1.97 % -4.08% -0.97% 5.59% 09:48
Natural gas 3.1400 0.002 -0.06 % 3.07% 5.17% 56.69% Apr/27
Gasoline 1.5450 0.0425 -2.67 % -7.63% -5.62% -3.44% 09:48
Heating oil 1.5042 0.0354 -2.30 % -5.01% -1.11% 6.78% 09:48
Ethanol 1.59 0.01 -0.31% -1.85% 1.92% 3.58% Apr/27
Naphtha 468.96 0.80 -0.17% -0.41% 2.59% 23.69% Apr/26
Propane 0.65 0.00 -0.11% -1.60% 6.51% 43.44% Apr/26
BUZ INVESTORS Wilbur Ross A day after announcing plans for a retaliatory tariff against Canadian lumber, U.S. Commerce Secretary Wilbur Ross

Wilbur Ross lays out plan to toughen up US trade policies

Wilbur Ross lays out plan to toughen up US trade policies




BUZ INVESTORS  Wilbur Ross A day after announcing plans for a retaliatory tariff against Canadian lumber, U.S. Commerce Secretary Wilbur Ross said Tuesday the Trump administration may also take action to protect America’s aluminum, semiconductor and shipbuilding industries as part of a newly aggressive trade policy.



Wilbur Ross

Ross told the Journal that reworking the North American Free Trade Agreement with Canada and Mexico was a priority, and that he hopes to completely rewrite the treaty by the end of the year.

Ross also said the U.S. may step in to support struggling Westinghouse Electric Co., the Toshiba Co. 6502, +2.27%  -owned builder of nuclear plants that filed for bankruptcy protection in March, in order to keep it out of the hands of Chinese buyers. “Having a nuclear-power capability is obviously a matter of national security,” Ross said.

Like up on FACEBOOK


Ebates Coupons and Cash Back

Market quotes are powered by
TradingView.com



Tech Stocks ( GOOG)   (MSFT ) ( AAPL ) (BBRY ) ( gopro )  ( WDC )




BUZ INVESTORS Russell 2000 hits intraday record The Russell 2000 hit a record in intraday trade on Wednesday as the market

Russell 2000 hits intraday record as sector most likely to benefit from Trump’s tax plan climbs

Russell 2000 hits intraday record as sector most likely to benefit from Trump’s tax plan climbs




BUZ INVESTORS  Russell 2000 hits intraday record The Russell 2000 hit a record in intraday trade on Wednesday as the market eagerly awaited a plan to overhaul corporate taxes set to be revealed by officials of President Donald Trump at 1:30 p.m. Eastern. The Russell 2000 , which tracks small-capitalization stocks, hit a high in intraday trade of 1,424.06, above its closing record of 1,413.64 set March 1, according to FactSet data. Another popular way to invest in the smallest companies in the S&P 500, the S&P Small Cap 600 touched a record of its own,



Russell 2000 hits intraday record

 

TRADE NOW

as did the iShares Russell 2000 ETF , which tracks the Russell 2000 closely. The small-cap sector has enjoyed a healthy run ahead of Trump’s tax announcement, largely because the president’s proposal calls for cutting the tax rate on owner-operated businesses to 15%. However, there are expected to be challenges to the administration’s new tax plan because it is likely to add to the U.S. deficit. Meanwhile, the Dow Jones Industrial Average is gaining 0.3% at 21,056, the S&P 500 index has gained 0.3% at 2,396–a few points from an intraday record–and the Nasdaq Composite Index was trading above Tuesday’s closing record, after it finished above 6,000 for the first time ever.

Like up on FACEBOOK


Ebates Coupons and Cash Back

Market quotes are powered by
TradingView.com



Tech Stocks ( GOOG)   (MSFT ) ( AAPL ) (BBRY ) ( gopro )  ( WDC )



GBPUSD Pound Jumps to 1.25, Markets Eye Autumn

GBPUSD Might Have Peaked, Watch Trump Tax Plan for Surprises

GBPUSD Might Have Peaked, Watch Trump Tax Plan for Surprises




GBPUSD

BUZ INVESTORS  GBPUSD Might Have Peaked At 09:40 GMT, the pair is trading at 1.2818, with the Pound trading 0.12% lower against US Dollar from the New York close. With no major economic releases in UK today, investors will look forward to global events for further direction. The pair witnessed a high of 1.2844 and a low of 1.2803 during the session. Yesterday, the Pound traded 0.08% higher against the US Dollar in the New York session and ended at 1.2834. Immediate downside, the first support level is seen at 1.2796, while on the upside, the first resistance level is situated at 1.2842.



GBPUSD Might Have Peaked

British Pound | Data | Chart | Calendar | Forecast | News

TRADE NOW 

The GBPUSD increased 0.0026 or 0.20% to 1.2858 on Wednesday April 26 from 1.2832 in the previous trading session. Historically, the British Pound reached an all time high of 2.86 in December of 1957 and a record low of 1.05 in February of 1985.

 

The GBPUSD spot exchange rate specifies how much one currency, the GBP, is currently worth in terms of the other, the USD. While the GBPUSD spot exchange rate is quoted and exchanged in the same day, the GBPUSD forward rate is quoted today but for delivery and payment on a specific future date. This page provides – British Pound – actual values, historical data, forecast, chart, statistics, economic calendar and news. British Pound – actual data, historical chart and calendar of releases – was last updated on April of 2017.

Like up on FACEBOOK


Ebates Coupons and Cash Back



major currencies: (EUR-USD) (USD-JPY) (USD-GBP) (USD-CHF), (USD-CAD), (AUD-USD)